NewsBenzingaSeaport Therapeutics : BPA du T3 à (0,49 $), supérieur à l’estimation de (0,58 $) Seaport Therapeutics : BPA du T3 à (0,49 $), supérieur à l’estimation de (0,58 $) Benzinga 2026.11.02 12:07 (GMT+0) Open on Benzinga Other news Citigroup Maintains Buy on Kodiak AI, Lowers Price Target to $7 Swoosh and a Miss: Nike Investor Day Leaves Wall Street Cold-Footed Wall Street Says the AI Trade Is Over — ETF Investors Aren’t Acting Like It Citigroup Maintains Neutral on Westlake, Lowers Price Target to $65 Citigroup Maintains Neutral on LyondellBasell Industries, Lowers Price Target to $66 Caterpillar's 'Best-In-Class' Construction Business Is Getting Overlooked, Analyst Says